investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Risk Prediction for ER Negative Breast Cancer Recurrence
Melissa L Bondy
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Carlos Caldas
Cancer Research UK (CRUK)
London, United Kingdom
Abenaa M Brewster
University of Texas MD Anderson Cancer Center
Houston, United States
Anne-Lise Borresen-Dale
University of Oslo
Oslo, Norway
Melissa L Bondy
Dan L. Duncan Cancer Center
Waco, United States
Related projects
Fergus J Couch
Risk and Penetrance of Mutations from Breast Cancer Testing Panels
Breast
Deborah W Bruner
Community Clinical Oncology Program (Radiation Therapy Oncology Group)
Breast
Radiation Oncology
Global Noncommunicable Diseases Intiatives
Bus-Race for Cure
Breast
Marsha A Moses
(PQA2): Escape from breast tumor dormancy: convergence of obesity and menopause
Breast
Pathology
Edwin G Wilkins
Mastectomy Reconstruction Outcome Consortium (MROC Study)
Breast
Gary Gilliland
Cancer Center Support Grant (comprehensive)
Breast
Ross L Prentice
Nutrition and Physical Activity Assessment Study (NPAAS)
Breast
Timothy L Lash
New and Integrated Perspectives on Modification of Tamoxifen Effectiveness
Breast
Naoto Ueno
Targeting the Variant Form of CD44 in Triple-Negative and Inflammatory Breast Cancer
Breast